Terms: = Endocrine gland cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889
52 results:
1. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.
Obermann R; Yemane B; Jarvis C; Franco FM; Kyriukha Y; Nolan W; Gohara B; Krezel AM; Wildman SA; Janetka JW
ChemMedChem; 2024 Apr; 19(8):e202300648. PubMed ID: 38300970
[TBL] [Abstract] [Full Text] [Related]
2. Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid cancer.
Hurst ZA; Liyanarachchi S; Brock P; He H; Nabhan F; Veloski C; Toland AE; Ringel MD; Jhiang SM
Thyroid; 2024 Mar; 34(3):378-387. PubMed ID: 38062767
[No Abstract] [Full Text] [Related]
3. Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic cancers with DNA Damage Repair Deficiencies.
Restifo D; McDermott JR; Cvetkovic D; Dos Santos T; Ogier C; Surumbayeva A; Handorf EA; Schimke C; Ma C; Cai KQ; Olszanski AJ; Kathad U; Bhatia K; Sharma P; Kulkarni A; Astsaturov I
Mol Cancer Ther; 2023 Oct; 22(10):1182-1190. PubMed ID: 37552607
[TBL] [Abstract] [Full Text] [Related]
4. Prediction of the survival of patients with advanced-stage ovarian cancer patients undergoing interval cytoreduction with the use of computed tomography reevaluation after neoadjuvant chemotherapy.
Li JY; Wang R
J Obstet Gynaecol Res; 2023 Nov; 49(11):2700-2710. PubMed ID: 37528642
[TBL] [Abstract] [Full Text] [Related]
5. Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases.
Duchnowska R; Supernat AM; Pęksa R; Łukasiewicz M; Stokowy T; Ronen R; Dutkowski J; Umińska M; Iżycka-Świeszewska E; Kowalczyk A; Och W; Rucińska M; Olszewski WP; Mandat T; Jarosz B; Bieńkowski M; Biernat W; Jassem J
Sci Rep; 2022 Nov; 12(1):20537. PubMed ID: 36446793
[TBL] [Abstract] [Full Text] [Related]
6. Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in
Astiazaran-Symonds E; Graham C; Kim J; Tucker MA; Ingvar C; Helgadottir H; Pastorino L; van Doorn R; Sampson JN; Zhu B; Bruno W; Queirolo P; Fornarini G; Sciallero S; Carter B; Hicks B; Hutchinson A; Jones K; Stewart DR; Chanock SJ; Freedman ND; Landi MT; Höiom V; Puig S; Gruis N; Yang XR; Ghiorzo P; Goldstein AM
JCO Precis Oncol; 2022 Nov; 6():e2200145. PubMed ID: 36409970
[TBL] [Abstract] [Full Text] [Related]
7. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2018 and Annual Treatment Report for 2013.
Nagase S; Ohta T; Takahashi F; Yamagami W; Yaegashi N;
J Obstet Gynaecol Res; 2022 Mar; 48(3):541-552. PubMed ID: 35026864
[TBL] [Abstract] [Full Text] [Related]
8. Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.
Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2110-e2123. PubMed ID: 34922358
[TBL] [Abstract] [Full Text] [Related]
9. Building the What Comes Next Cohort for
Dossa F; Metcalfe K; Sutradhar R; Little T; Eisen A; Chun K; Meschino WS; Velsher L; Ellis JL; Baxter NN
CMAJ Open; 2021; 9(3):E874-E885. PubMed ID: 34870614
[TBL] [Abstract] [Full Text] [Related]
10. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract] [Full Text] [Related]
11. Rates of Thy 1-non-diagnostic thyroid fine needle aspiration using the UK Royal College of Pathologists Thy Terminology. A systematic review of the literature comparing patients who undergo rapid on-site evaluation and those who do not.
Poller DN; Doyle V; Trimboli P; Bongiovanni M
Cytopathology; 2020 Nov; 31(6):502-508. PubMed ID: 32003044
[TBL] [Abstract] [Full Text] [Related]
12. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
[TBL] [Abstract] [Full Text] [Related]
13. Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic cancer.
Goldstein JB; Zhao L; Wang X; Ghelman Y; Overman MJ; Javle MM; Shroff RT; Varadhachary GR; Wolff RA; McAllister F; Futreal A; Fogelman DR
Clin Cancer Res; 2020 Mar; 26(6):1385-1394. PubMed ID: 31871297
[TBL] [Abstract] [Full Text] [Related]
14. CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling.
Codilupi T; Taube D; Naegeli H
BMC Cancer; 2019 Nov; 19(1):1042. PubMed ID: 31690264
[TBL] [Abstract] [Full Text] [Related]
15. ERCC1-xpf deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.
Mesquita KA; Alabdullah M; Griffin M; Toss MS; Fatah TMAA; Alblihy A; Moseley P; Chan SYT; Rakha EA; Madhusudan S
Gynecol Oncol; 2019 May; 153(2):416-424. PubMed ID: 30797591
[TBL] [Abstract] [Full Text] [Related]
16. Pancreatoduodenectomy with colon resection for pancreatic cancer: a systematic review.
Solaini L; de Rooij T; Marsman EM; Te Riele WW; Tanis PJ; van Gulik TM; Gouma DJ; Bhayani NH; Hackert T; Busch OR; Besselink MG
HPB (Oxford); 2018 Oct; 20(10):881-887. PubMed ID: 29705346
[TBL] [Abstract] [Full Text] [Related]
17. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic values of excision repair cross-complementing genes mRNA expression in ovarian cancer patients.
Zhao M; Li S; Zhou L; Shen Q; Zhu H; Zhu X
Life Sci; 2018 Feb; 194():34-39. PubMed ID: 29247747
[TBL] [Abstract] [Full Text] [Related]
19. The telomere-binding protein TRF2 is required for metronomic therapeutic effects of gemcitabine and capecitabine.
Lee WP; Lan KH; Li CP; Chao Y; Hou MC; Lin HC; Lee SD
Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):917-928. PubMed ID: 28088627
[TBL] [Abstract] [Full Text] [Related]
20. MUS81 is associated with cell proliferation and cisplatin sensitivity in serous ovarian cancer.
Xie S; Zheng H; Wen X; Sun J; Wang Y; Gao X; Guo L; Lu R
Biochem Biophys Res Commun; 2016 Aug; 476(4):493-500. PubMed ID: 27255997
[TBL] [Abstract] [Full Text] [Related]
[Next]
